Related Experiment Videos
Fatty acid composition of adipose tissue in patients with coronary heart disease
Insights
Lower stearic acid levels in adipose tissue may indicate a higher risk of coronary heart disease (CHD). This finding suggests stearic acid could be a potential biomarker for heart disease, warranting further investigation into its metabolic role.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
Background:
- Coronary heart disease (CHD) is a leading cause of mortality worldwide.
- Understanding the role of dietary and tissue fatty acids in CHD pathogenesis is crucial for prevention strategies.
Purpose of the Study:
- To investigate the association between adipose tissue fatty acid composition and the presence of coronary heart disease.
- To identify specific fatty acids that may serve as indicators for CHD risk.
Main Methods:
- A comparative study involving male patients with acute myocardial infarction and a control group without CHD.
- Exclusion criteria included diabetes, endocrine disorders, liver/kidney diseases, and recent weight or diet changes.
- Multivariate discriminant analysis was employed to identify discriminating factors.
Main Results:
- A statistically significant lower proportion of stearic acid was found in the adipose tissue of CHD patients compared to controls (3.25% vs. 4.13%).
- Age was the strongest discriminator between groups, followed by stearic acid.
- Other fatty acids, body weight, and skinfold measurements did not significantly differentiate the groups.
Conclusions:
- Stearic acid proportion in adipose tissue may be a potential indicator for coronary heart disease.
- The metabolic mechanisms linking stearic acid to CHD require further elucidation.
- Additional research is needed to confirm the significance of stearic acid as a CHD biomarker.
Abstract:
In order to study the relationship between the fatty acid composition of adipose tissue and coronary heart disease (CHD), 34 consecutive male patients with acute myocardial infarction and 33 hospitalized men free of CHD were compared. Patients with diabetes mellitus, endocrine disorders, liver and kidney diseases, recent changes in body weight and deviations from the "normal", customary diet were exlcuded. A statistically significant difference between the two groups was observed only in stearic acid, its proportion being lower in CHD patients (3.25% vs. 4.13%). Using multivariate discriminant analysis, age discriminated best between the groups, followed by stearic acid. The signs observed were positive for the former and negative for the latter. All other acids, relative body weight, and skinfold measurements did not significantly contribute to the discrimination. Age did not correlate with the proportion of stearic acid. Blood lipids from samples taken within 24 h of admission did not significantly differ between the groups. Three months later they had risen considerably in the infarct patients. The metabolic basis of the relationship between CHD and stearic acid is not clear at present. Additional studies are necessary to substantiate the importance of this acid as an indicator of CHD.